Vicente Balanzá Martínez-rekin lankidetzan egindako argitalpenak (27)

2023

  1. Obstetric complications and clinical presentation in first episode of psychosis

    Acta Neuropsychiatrica

  2. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

2022

  1. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

2021

  1. Humanization in mental health plans in Spain

    Revista de Psiquiatria y Salud Mental

  2. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  3. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

2018

  1. Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 5, pp. 441-455

  2. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  3. Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711

  4. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

  2. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  3. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  4. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

  5. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

  6. The microbiota and gut-brain axis: Contributions to the immunopathogenesis of schizophrenia

    Current Pharmaceutical Design, Vol. 22, Núm. 40, pp. 6122-6133